Earkart Limited
Earkart an Indian tech-driven hearing healthcare company dedicated to making advanced audiology services and hearing aids more accessible, affordable, and transparent. Listed on the BSE SME platform, it operates across India and neighboring countries, specializing in both manufacturing and distributing modern digital hearing solutions
- Market Cap ₹ 153 Cr.
- Current Price ₹ 111
- High / Low ₹ 231 / 104
- Stock P/E 40.2
- Book Value ₹ 47.4
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2026 | |
|---|---|
| 54.04 | |
| Sales growth | |
| 45.69 | |
| Operating Profit | 8.35 |
| OPM % | 15.45% |
| 0.11 | |
| Interest | 0.54 |
| Depreciation | 0.66 |
| Profit before tax | 7.26 |
| Tax % | 31.96% |
| 4.93 | |
| EPS in Rs | 3.58 |
| Dividend Payout % | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -53% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2026 | |
|---|---|
| Equity Capital | |
| Reserves | |
| Total Liabilities | |
| CWIP | |
| Investments | |
| Total Assets |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2026 | |
|---|---|
| Net Cash Flow | |
| Free Cash Flow | |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit |
Ratios
Consolidated / View Standalone
| Mar 2026 | |
|---|---|
| Debtor Days | |
| Inventory Days | |
| Days Payable | |
| Cash Conversion Cycle | |
| Working Capital Days | |
| ROCE % |
Insights
In beta| Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Government Revenue Share % ・Standalone data |
|
||||
| Cities Presence cities ・Standalone data |
|||||
| Dealer Partners dealers ・Standalone data |
|||||
| Hearing Aid Production Capacity units/year ・Standalone data |
|||||
| Hearing Aid Production Volume units/year ・Standalone data |
|||||
| Manufacturing & Office Area sq ft ・Standalone data |
|||||
| SIS (Shop-in-Shop) Clinics clinics ・Standalone data |
|||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Acquisition
- Board approved H1 FY2026 results and incorporation of a wholly-owned subsidiary in Australia.
-
Unaudited Standalone And Consolidated Financial Results Of The Company For The Half Year Ended 30 September 2026, Along With Limited Review Report Issued By The Peer Reviewed Auditor M/S Timsi & Associates,, Chartered Accountants.
- Earkart posted H1 FY27 standalone PAT of Rs116.68 lakh; consolidated PAT Rs71.77 lakh, approved 5 Nov 2026.
-
Board Meeting Outcome for Board Meeting Outcome For Outcome Of The Meeting Of The Board Of Earkart Limited Held On Thursday, 05 November 2026.
- Earkart approved Q2 FY27 results and incorporation of a wholly-owned Australia subsidiary on 5 Nov 2026.
-
Board Meeting Intimation for Prior Intimation Of Board Meeting To Held On Thursday, 05Th Of November 2026 For Approval Of Unaudited Half Yearly Financial Result For The Half Year Ending 30 September, 2026
- Board meets on 5 November 2026 to approve H1 FY2026 results and a wholly owned Australia subsidiary.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Compliance Certificate under Reg 74(5) of SEBI (DP) Regulation, 2018 confirming the dematerialization details to depositories
Concalls
-
Jun 2026PPT
-
Jan 2026REC
-
Dec 2025Transcript PPT
Business Profile:[1]
Earkart manufactures and distributes modern hearing aids
(BTE & RIC) and accessories, trades third-party hearing aids
and parts, and also supplies mobility aids (foldable walkers)
and educational/therapy kits (MSIED and TLM) for children
with disabilities.